Identification and production of bioflocculants by Enterobacter sp. and Bacillus sp. and their characterization studies

Prep Biochem Biotechnol. 2017 May 28;47(5):458-467. doi: 10.1080/10826068.2017.1292287. Epub 2017 Feb 16.

Abstract

In this work, two bioflocculants, namely, EB-EPS and B1-EPS, were derived from Enterobacter sp. and Bacillus sp., respectively, and analyzed with regard to their production and characterization. About 0.9 and 0.16 g of purified EB and B1 were obtained from I L of fermentation broth. Chemical analysis showed the contents of purified EB and B1 mainly as 88.7 and 92.8% (w/w) of carbohydrate, and 11.3 and 21.8% (w/w) protein, respectively. Fourier-transform infrared spectrometry analysis revealed the presence of hydroxyl, amide, and carboxyl groups in the identified bioflocculant. Thermogravimetric analysis (TGA) results exhibited enhanced thermal stability with a minimum mass loss of 50% while 25% were found to have occurred at higher temperatures (>400°C) for microbe-derived compounds EB and B1 leading to the possibility of using these compounds as fillers or for fabricating composite films for high-temperature applications. Further, the compounds from both the bacteria exhibited good antibacterial characteristics against pathogenic Escherichia coli. Degradability study of bioflocculant-embedded composite films shows the possibility of attaining eco-friendly bioremediation. Accordingly, experimental results revealed the suitability of developed composite films as a suitable alternative for food packaging and biomedical applications.

Keywords: Antibacterial; TGA; differential scanning calorimetry; microbe-derived bioflocculant.

MeSH terms

  • Anti-Bacterial Agents / isolation & purification
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology
  • Bacillus / chemistry
  • Bacillus / metabolism*
  • Biodegradation, Environmental
  • Biopolymers / isolation & purification
  • Biopolymers / metabolism*
  • Biopolymers / pharmacology
  • Enterobacter / chemistry
  • Enterobacter / metabolism*
  • Escherichia coli / drug effects
  • Escherichia coli Infections / drug therapy
  • Fermentation
  • Flocculation
  • Humans
  • Industrial Microbiology*

Substances

  • Anti-Bacterial Agents
  • Biopolymers